#AbbottLabs' beat-and-raise report struggles to overcome a string of headwinds in Q2 $ABT $UNH $THC $HCA $UHS $SGRY  https://t.co/UmIMwpd7jE #earnings #laboratory #medicaldevice #healthcare #products #supplier #China #lockdowns #COVID #babyformula #shortage #stockmarket